Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelets Induced Vasodilation in Arteriopathy
NCT00152646Phase 4Unknown
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Mar 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of aspirin and clopidogrel in Peripheral Arterial Disease (PAD) (2 arms), sponsored by Centre Hospitalier Universitaire d'Angers. Primary endpoints: In vivo vasodilation induced by low intensity current at 7 days, In vitro study of platelets function at 7 days and 1 more. Status: unknown.
02
Drugs
aspirinclopidogrel
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT00152646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152646.